Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling overly positive on these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that investors might want to hear about are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.

Image source: Getty Images

A2 Milk Company Ltd (ASX: A2M)

According to a note out of Citi, its analysts have downgraded this struggling infant formula company's shares to a sell rating and slashed their price target on them to $4.80. Citi has a number of concerns which it appears to believe have shifted the risks to the downside. These include supply disruption in China following lockdowns, weak pricing on Chinese ecommerce reseller platforms, and delays with its SAMR re-registration. Citi notes that the latter is far from guaranteed and could materially impact its sales should it not be granted. The A2 Milk share price is trading at $5.04 on Sunday.

IGO Ltd (ASX: IGO)

A note out of UBS reveals that its analysts have initiated coverage on this battery materials miner's shares with a sell rating and $12.65 price target. Although UBS notes that IGO provides investors with exposure to an attractive area of the resources sector, it isn't enough for a more positive rating. This is due to concerns over its current valuation. In addition, UBS fears that current lithium and nickel prices are unsustainable. The IGO share price was fetching $13.68 at Friday's close.

Magellan Financial Group Ltd (ASX: MFG)

Analysts at Macquarie have retained their underperform rating but lifted their price target on this fund manager's shares to $13.25. This follows the release of Magellan's latest funds under management update. While Macquarie was pleased to see Magellan's fund outflows slow, it thinks it may be too soon to get excited. The broker isn't expecting the outflows to stop any time soon. Particularly given the poor investment performance of its funds. The Magellan share price ended the week at $16.95.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
Broker Notes

6 ASX 200 shares boosted by brokers this week

Brokers have increased their ratings on CSL, NAB, Ramsay Health Care, and others this week. 

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

Buy, hold, sell: Aurizon, Car Group, Guzman y Gomez shares

Toby Grimm from Baker Young explains his views and ratings on three ASX 300 shares.

Read more »

Broker looking at the share price.
Broker Notes

Buy, hold, sell: Temple & Webster, Kelsian, Boss Energy shares

Two experts share their views on three ASX shares.

Read more »

A man in a business suit holds his coffee cup aloft as he throws his head back and laughs heartily.
Broker Notes

3 ASX 200 shares forecast to fly 30% to 40% higher

Here's the latest broker forecasts.

Read more »

A mother and her two adult daughters embrace outdoors.
Broker Notes

Buy, hold, sell: AGL Energy, Telstra, Zip shares

Here are brokers' latest verdicts on these three major ASX 200 shares.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

This ASX biotech could jump more than 30%, one broker says

This company's core business is performing well, the broker says.

Read more »

Couple using their digital tablet together.
Broker Notes

These ASX 200 shares could return 50% to 85%

Analysts have good things to say about these shares.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

This ASX small cap could jump more than 100%: Broker

A new acquisition could drive early cash flow.

Read more »